Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.
Evan M BlochRuchika GoelSilvano WendelThierry BurnoufArwa Z Al-RiyamiAi Leen AngVincenzo DeAngelisLarry J DumontKevin LandCheuk Kwong LeeAdaeze OrehGopal Kumar PatidarSteven L SpitalnikMarion VermeulenSalwa I HindawiKarin Van den BergPierre TiberghienHans VrielinkPampee YoungDana DevineCynthia So-OsmanPublished in: Vox sanguinis (2020)
There has been wide-scale adoption of CCP in many HICs, which could increase if clinical trials show efficacy of use. By contrast, LMICs, having received little attention, require locally applicable strategies for adoption of CCP.